The growing challenge of pediculosis capitis – more commonly called head lice – is presenting exacerbated by the widespread development immunity to standard treatments. Thankfully, researchers are unveiling promising approaches to fight these difficult infestations. Emerging therapies feature enzyme-based products which uniquely inactivate lice